ES482549A0 - Un metodo para la preparacion de una composicion de virus herpes - Google Patents

Un metodo para la preparacion de una composicion de virus herpes

Info

Publication number
ES482549A0
ES482549A0 ES482549A ES482549A ES482549A0 ES 482549 A0 ES482549 A0 ES 482549A0 ES 482549 A ES482549 A ES 482549A ES 482549 A ES482549 A ES 482549A ES 482549 A0 ES482549 A0 ES 482549A0
Authority
ES
Spain
Prior art keywords
preparation
herpes virus
virus composition
vaccine
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES482549A
Other languages
English (en)
Spanish (es)
Other versions
ES8107300A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES8107300A1 publication Critical patent/ES8107300A1/es
Publication of ES482549A0 publication Critical patent/ES482549A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
ES482549A 1978-07-21 1979-07-17 Un metodo para la preparacion de una composicion de virus herpes Granted ES482549A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92706978A 1978-07-21 1978-07-21

Publications (2)

Publication Number Publication Date
ES8107300A1 ES8107300A1 (es) 1980-12-16
ES482549A0 true ES482549A0 (es) 1980-12-16

Family

ID=25454121

Family Applications (1)

Application Number Title Priority Date Filing Date
ES482549A Granted ES482549A0 (es) 1978-07-21 1979-07-17 Un metodo para la preparacion de una composicion de virus herpes

Country Status (12)

Country Link
EP (1) EP0008255B1 (cg-RX-API-DMAC10.html)
JP (1) JPS5519271A (cg-RX-API-DMAC10.html)
AT (1) ATE3058T1 (cg-RX-API-DMAC10.html)
AU (1) AU532186B2 (cg-RX-API-DMAC10.html)
DE (1) DE2965191D1 (cg-RX-API-DMAC10.html)
DK (1) DK306379A (cg-RX-API-DMAC10.html)
ES (1) ES482549A0 (cg-RX-API-DMAC10.html)
HU (1) HU182530B (cg-RX-API-DMAC10.html)
IE (1) IE48379B1 (cg-RX-API-DMAC10.html)
PL (1) PL217216A1 (cg-RX-API-DMAC10.html)
PT (1) PT69953A (cg-RX-API-DMAC10.html)
RO (1) RO76563A2 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9808922D0 (en) * 1998-04-24 1998-06-24 Cantab Pharmaceuticals Res Ltd Virus preparations
FR2804026B1 (fr) 2000-01-21 2004-06-11 Merial Sas Vaccination contre l'herpesvirose canine et vaccins
ES2765880T3 (es) 2012-01-09 2020-06-11 Sanofi Pasteur Biologics Llc Purificación del virus del herpes
WO2013177172A2 (en) 2012-05-21 2013-11-28 Sanofi Pasteur Limited Herpesvirus compositions and related methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3783098A (en) * 1971-08-10 1974-01-01 Cornell Res Foundation Inc Highly potent,viable and stable cellfree virus preparations from cells infected with cell-associated viruses and method for obtaining the same
US3981771A (en) * 1973-07-19 1976-09-21 Martin Sevoian Marek's disease vaccine
US3959466A (en) * 1974-04-15 1976-05-25 The Wistar Institute Highly attenuated cytomegalovirus vaccine and production thereof

Also Published As

Publication number Publication date
DE2965191D1 (en) 1983-05-19
IE48379B1 (en) 1984-12-26
ES8107300A1 (es) 1980-12-16
RO76563A2 (ro) 1981-04-30
AU4882079A (en) 1980-01-24
EP0008255B1 (en) 1983-04-13
PT69953A (en) 1979-08-01
EP0008255A1 (en) 1980-02-20
HU182530B (en) 1984-01-30
DK306379A (da) 1980-01-22
JPS6332768B2 (cg-RX-API-DMAC10.html) 1988-07-01
ATE3058T1 (de) 1983-04-15
PL217216A1 (cg-RX-API-DMAC10.html) 1980-12-15
JPS5519271A (en) 1980-02-09
AU532186B2 (en) 1983-09-22

Similar Documents

Publication Publication Date Title
DK0764029T4 (da) Proteinadjuvanser
MX9306841A (es) Vacuna a base de ureasa contra la infeccion por helicobacter en mamiferos.
FR2522967B1 (fr) Conjugues d'haptenes et de muramyl-peptides, doues d'activite immunogene et compositions les contenant
ATE95564T1 (de) Aeusseres membranprotein f von pseudomonas aeruginosa.
ES482549A0 (es) Un metodo para la preparacion de una composicion de virus herpes
DK16087A (da) Mastitis-vaccine
DK0626008T3 (da) Vaccine, der som en adjuvans indeholder acemannan
ES2060740T3 (es) Vacunas de virus vivos para la enfermedad de newcastle.
IT7928341A0 (it) Procedimento per la preparazione di vaccini contro il virus della meningoencefalite estiva precoce e vaccini cosi' preparati.
EP0496787A4 (en) Novel infectious bursal disease virus
ATE84722T1 (de) Tollwut-lebendimpfstoff.
DK257887D0 (da) Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden
NL300073I1 (nl) Vaccin.
ATE18007T1 (de) Hepatitisimpfstoff.
ATE39055T1 (de) Verfahren zur immunisierung von schweinen gegen die aujeszky-krankheit.
DK569985A (da) Vaccine indeholdende inaktiveret infektioes fuglebronkitisvirus
Felfe et al. Trends in production of foot-and-mouth disease vaccine.
RU94031386A (ru) Вакцина сухая культуральная против вирусного энтерита гусей и способ профилактики и лечения вирусного энтерита гусей
Dardanoni et al. Vaccination against hepatitis B: Evaluation of the prevaccination markers.
ATE159758T1 (de) Azelluläre impfstoffe
Wawrzkiewicz et al. Biological properties of distemper attenuated strain propagated in chick fibroblasts in the medium of own production.
ES516673A0 (es) "un metodo para preparar una vacuna para estimular la produccion de anticuerpos contra el virus de la glosopeda".
UA21969A1 (uk) Спосіб виготовлеhhя іhактивоваhої культуральhої вакциhи проти хвороби ауескі
ES2055687T3 (es) Vacuna de virus.
RU95104924A (ru) Штамм вируса герпеса кур "50" - деп для изготовления вакцины против болезни марека

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303